Imptox People: Lea Ann Dailey

<p>Lea Ann Dailey works with a wide range of biomaterials, including polymeric, lipidic and protein-based nano-systems, to characterise nanomaterials&#39; in vitro and in vivo behaviour designed for use as nano-medicines. Knowledge gained through studying first nanomaterial biocompatibility and then biodistribution profiles is used to subsequently select the most promising nanoparticle platforms for drug encapsulation and development towards different therapeutic or diagnostic strategies. The Imptox project has received funding from the EU&rsquo;s H2020 framework program for research and innovation under grant agreement n. 965173</p>